IG-ICC is correlated with the most favorable outcome [14,15], and the upregulation of EGFR has been detected in 100% (9/9) of poorly differentiated non-intraductal growth ICC subtypes, which is correlated with a poorer outcome [16]. Here, EGFR is linked to intrahepatic cholangiocarcinoma.